Literature DB >> 29103540

Emerging Concepts in Gastric Neoplasia: Heritable Gastric Cancers and Polyposis Disorders.

Rachel S van der Post1, Fátima Carneiro2.   

Abstract

Hereditary gastric cancer is a relatively rare disease with specific clinical and histopathologic characteristics. Hereditary gastric cancer of the diffuse type is predominantly caused by germline mutations in CDH1. The inherited cause of familial intestinal gastric cancer is unknown. Gastric adenocarcinoma and proximal polyposis of the stomach is a hereditary cancer syndrome caused by germline mutations in promoter 1B of APC. Other well-defined cancer syndromes, such as Lynch, Li-Fraumeni, and hereditary breast or ovarian cancer syndromes, are associated with increased risk of gastric cancer. This article reviews important histopathologic features and emerging concepts regarding gastric carcinogenesis in these syndromes.
Copyright © 2017 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  CDH1; CTNNA1; E-cadherin; GAPPS; Gastric polyposis; Hereditary gastric cancer; Signet ring cell; Stomach

Mesh:

Year:  2017        PMID: 29103540     DOI: 10.1016/j.path.2017.07.011

Source DB:  PubMed          Journal:  Surg Pathol Clin        ISSN: 1875-9157


  11 in total

Review 1.  Resolving gastric cancer aetiology: an update in genetic predisposition.

Authors:  Paul C Lott; Luis G Carvajal-Carmona
Journal:  Lancet Gastroenterol Hepatol       Date:  2018-12

Review 2.  Hereditary gastric cancer: what's new? Update 2013-2018.

Authors:  Rachel S van der Post; Carla Oliveira; Parry Guilford; Fátima Carneiro
Journal:  Fam Cancer       Date:  2019-07       Impact factor: 2.375

3.  Germline variants and phenotypic spectrum in a Canadian cohort of individuals with diffuse gastric cancer.

Authors:  M Aronson; C Swallow; A Govindarajan; K Semotiuk; Z Cohen; P Kaurah; L Velsher; I Ambus; K Buckley; C Forster-Gibson; W S Meschino; A Blumenthal; R H Kim; S Brar
Journal:  Curr Oncol       Date:  2020-05-01       Impact factor: 3.677

4.  Indications for Total Gastrectomy in CDH1 Mutation Carriers and Outcomes of Risk-Reducing Minimally Invasive and Open Gastrectomies.

Authors:  Elvira L Vos; Erin E Salo-Mullen; Laura H Tang; Mark Schattner; Sam S Yoon; Hans Gerdes; Arnold J Markowitz; Diana Mandelker; Yelena Janjigian; Kenneth Offitt; Daniel G Coit; Zsofia K Stadler; Vivian E Strong
Journal:  JAMA Surg       Date:  2020-11-01       Impact factor: 14.766

Review 5.  Diffuse Gastric Cancer: A Summary of Analogous Contributing Factors for Its Molecular Pathogenicity.

Authors:  Shamshul Ansari; Boldbaatar Gantuya; Vo Phuoc Tuan; Yoshio Yamaoka
Journal:  Int J Mol Sci       Date:  2018-08-16       Impact factor: 5.923

Review 6.  The role of endoscopy in the management of hereditary diffuse gastric cancer syndrome.

Authors:  Shria Kumar; Jessica M Long; Gregory G Ginsberg; Bryson W Katona
Journal:  World J Gastroenterol       Date:  2019-06-21       Impact factor: 5.742

7.  Hereditary Diffuse Gastric Cancer: A Comparative Cohort Study According to Pathogenic Variant Status.

Authors:  Tim Marwitz; Robert Hüneburg; Isabel Spier; Jan-Frederic Lau; Glen Kristiansen; Philipp Lingohr; Jörg C Kalff; Stefan Aretz; Jacob Nattermann; Christian P Strassburg
Journal:  Cancers (Basel)       Date:  2020-12-11       Impact factor: 6.639

8.  Novel somatic variants in CTNNA1 gene in Iranian patients with diffuse gastric cancer.

Authors:  Mohadeseh Naghi Vishteh; Tayyeb Ali Salmani; Amirreza Javadi Mamaghani; Seyyed Javad Seyyed Tabaei; Majid Kheirollahi
Journal:  Gastroenterol Hepatol Bed Bench       Date:  2021

Review 9.  Clinical spectrum and pleiotropic nature of CDH1 germline mutations.

Authors:  Joana Figueiredo; Soraia Melo; Patrícia Carneiro; Ana Margarida Moreira; Maria Sofia Fernandes; Ana Sofia Ribeiro; Parry Guilford; Joana Paredes; Raquel Seruca
Journal:  J Med Genet       Date:  2019-01-19       Impact factor: 6.318

Review 10.  Precancerous lesions of the stomach, gastric cancer and hereditary gastric cancer syndromes.

Authors:  Irene Gullo; Federica Grillo; Luca Mastracci; Alessandro Vanoli; Fatima Carneiro; Luca Saragoni; Francesco Limarzi; Jacopo Ferro; Paola Parente; Matteo Fassan
Journal:  Pathologica       Date:  2020-09
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.